Study: Genetic Testing Results Does Not Change Demand for Follow-Up Services
Receiving testing results does not appreciably drive up or diminish test recipients’ demand for potentially costly follow-up health services.
Read MorePosted by Clinical Lab Products | May 18, 2012 | Miscellaneous |
Receiving testing results does not appreciably drive up or diminish test recipients’ demand for potentially costly follow-up health services.
Read MorePosted by Clinical Lab Products | May 11, 2012 | Miscellaneous |
MRSA/MSSA Blood Culture Test DISTINGUISHES MRSA VERSUS MSSA MicroPhage, Longmont, Colo, has received an additional FDA 510(k) clearance that significantly expands the market for its KeyPath™ MRSA/MSSA Blood Culture Test-BT. The
Read MorePosted by Clinical Lab Products | May 4, 2012 | Sexually Transmitted Diseases |
State of the art, but still tragically underused
Read MorePosted by Clinical Lab Products | May 2, 2012 | Blood Banking, Hematology & Serology, Miscellaneous |
Blood centers are facing today’s many challenges with the principles of total blood management
Read MorePosted by Clinical Lab Products | Apr 11, 2012 | Molecular Diagnostics |
SeraCare Life Sciences IncBiocare MedicalRubicon Genomics IncRandox Toxicology LtdQuest DiagnosticsVentana Medical Systems IncAdvanDx
Read More